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X-ray diffractionReceptors of the Cys-loop family are central to neurotransmission and primary therapeutic targets. In order to
decipher their gating and modulation mechanisms, structural data is essential. However, structural studies
require large amounts of pure, functional receptors. Here, we present the expression and puriﬁcation of
the mouse serotonin 5-HT3 receptor to high purity and homogeneity levels. Inducible expression in human
embryonic kidney 293 cells in suspension cultures with orbital shaking resulted in yields of 6–8 mg receptor
per liter of culture. Afﬁnity puriﬁcation using a strep tag provided pure protein in active form. Further
deglycosylation and removal of the puriﬁcation tag led to a pentameric receptor after size-exclusion chroma-
tography, at the milligram scale. This material is suitable for crystallography, as demonstrated by X-ray dif-
fraction of receptor crystals at low resolution.
© 2013 Elsevier B.V. All rights reserved.1 . Introduction
Rapid signal transduction betweenneuronal cells relies on the conver-
sion of a chemical signal—the vesicular release of neurotransmitters—into
a transmembrane electrical signal —the activation of ligand-gated
channels—. The cys-loop receptor (CLR) family directlymediates this con-
version [1]. CLRs aremultimeric andmultidomain receptors, comprisedof
ﬁve subunits. Each subunit consists of an extracellular ligand-binding do-
main, a pore domain of four transmembrane helices and an intracellular
domain highly variable in sequence and length (Figs. 1 and SI 1).
Mammalian CLRs are grouped into four categories according to the li-
gand they recognize and the type of ions they conduct. γ-aminobutyric
acid (GABA) and glycine receptors present anion selective channels and
thus participate in the inhibitory transmission while receptors activated
by acetylcholine and serotonin (5-HT for 5-hydroxytryptamine) are cat-
ion selective and propagate excitatory signals. The serotonin 5-HT3 re-
ceptor plays a role in emesis, memory, anxiety, and substance addiction
within the central nervous system [2,3], and also regulates intestinalmo-
tility and secretion throughout the entire gastrointestinal tract, where
most of the body's serotonin reserves are found. There are other subtypes
of serotonin receptors, but 5-HT3 is the only pentameric ligand-gated
channel as all others belong to the family of G protein-coupled receptors
(GPCRs).
Because of their pivotal role in neurotransmission, a number of
psycho-active and therapeutic compounds target the CLRs and mod-
ulate their activity, including alcohol, antidepressants, steroids, localgues.nury@epﬂ.ch (H. Nury).
l rights reserved.and general anesthetics [1]. More speciﬁcally, prominent molecules
affecting 5-HT3 receptor pharmacology represent a series of antago-
nists widely used as anti-emetic drugs following chemotherapy or
for postoperative prevention of nausea and vomiting [4].
The molecular mechanisms of action of most of these drugs are
unknown; the fundamental questions of conformational transitions
between the closed and open channel states, of selectivity, of
single-channel conductance determinants, are not fully understood.
High-resolution structures of homologues in a variety of conductive
(GLIC from bacteria [5], and GluCl from Caenorhabditis elegans [6]) and
non-conductive (GLICmutants [7], ELIC frombacteria [8]) states provide
a ﬁrst structural framework, but atomic information of pharmacologi-
cally relevant mammalian receptors is acutely missing. In this context
the 5-HT3 receptor is a valid candidate among mammalian CLRs for
crystallographic studies. First, the 5-HT3A subunit forms functional
homomeric receptors [9], simplifying the expression and complexity
of assembly compared to most GABAA and nicotinic acetylcholine
(nACh) receptors that form heteropentamers comprising two, three or
four different subunits. Secondly, 5-HT3A has been reported to provide
superior expression in heterologous systems in comparison to other
(homomeric) receptors of the family [10].
The 5-HT3 receptor was ﬁrst shown to function as a ligand-gated ion
channel in 1989 [11]. It was ﬁrst cloned in 1991 [9]; soon after the
pentameric ultrastructure of the receptor was deciphered [12] and its
heterologous over-expression and puriﬁcation were reported [13,14].
Since then functional, pharmacological, and physiological characteriza-
tion of the 5-HT3 receptor has ﬂourished (for review see [2,3,15,16]).
However, promises of high-resolution structural data from thepioneering
years have not been fulﬁlled yet, which reﬂects a general shortcoming in
structure determination of mammalian membrane proteins. Major
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Fig. 1. Topology of the 5-HT3A receptor. a. Illustration of one subunit composed of the β-folded extracellular domain, the transmembrane domain comprising four α-helices and the
intracellular partially structured domain inserted between transmembrane helices M3 and M4. The three main glycosylation sites are indicated by green ball-and-sticks. The tags
and the TEV protease cleavage site are schematically represented for the two constructs mainly used in this work: Strep4 (black line) and Strep1−His10 (dashed line) b. The active
receptor is made up of ﬁve subunits with the ion channel along the central ﬁve-fold symmetry axis (dashed line) and the orthosteric binding site at the interface between subunits
(yellow disk). Connecting loops are omitted for clarity.
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gous expression systems that produce sufﬁcient amounts of proteins in
the cell membrane and (ii) developing proper protocols to solubilize
and purify homogeneous, active, and stable proteins for crystallization
experiments [17]. Here we report milligram-scale expression and puriﬁ-
cation of the mouse 5-HT3A receptor using mammalian cell lines. Proce-
dures were optimized to extract and purify the receptor in complex with
detergent in a functional pentameric state. The pure protein–detergent
complex met crystallographic standards, and readily yielded 5-HT3
receptor crystals, a decisive milestone in the journey toward a high-
resolution structure.
2. Results
2.1. Functional expression of the mouse 5-HT3 receptor at the
plasma membrane
We generated constructs consisting of DNA encoding the mouse se-
rotonin 5-HT3A receptor signal sequence, a Strep puriﬁcation tag, a TEV
protease cleavage site, the mature 5-HT3A receptor and, in some cases,
a poly-histidine tag (see theMaterial andmethods section). For expres-
sion in mammalian cells, these constructs were inserted into the
pcDNA5/TO vector or into the pACMV/TetO vector (gift by P. J. Reeves).
These vectors, which are primarily designed for expression upon
tretracycline induction in speciﬁc cells (see below Section 2.2), can
also be used for transient transfection. One day after plasmid transfec-
tion, CHO and HEK293 cells displayed an equivalent and robust plasma
membrane expression of functional receptor. First, a Chromeo-546
ﬂuorophore coupled to Streptactin and speciﬁc to the N-terminal
Strep tag, applied to the culture medium, stained the cell plasmamem-
branes during in vivo labeling experiments (Figs. 2a and SI 1). Second,
GR-ﬂu, a speciﬁc antagonist of the 5-HT3 receptor known to bind to
the orthosteric binding site located at the interfaces of extracellular do-
mains [18], also stained themembrane, conﬁrming the correct insertion
and assembly of the receptor (Figs. 2b and SI 2). From measuring thebinding of the radioactive antagonist [3H]-GR65630, we estimated a
mean expression of 1–2 × 106 receptors per cell. Furthermore whole
cell electrophysiological recordings showed currents elicited by the ap-
plication of serotonin with an EC50 value around 7 μM (Fig. 2c).
2.2. A high-yield and efﬁcient recombinant expression
Scaling-up this transient expression system to make it amenable for
crystallization trials was not straightforward. The efﬁciency of transfec-
tion was severely decreased for liter scale cultures and varied from one
trial to another. In order to overcome this problem and to increase the
amount of receptor expressed, we switched to stable cell lineswith an in-
ducible system in which the protein expression is repressed in the ab-
sence and induced in the presence of tetracycline [19]. First of all, T-REx
CHO and T-REx 293 cells were transfected with pcDNA5/TO constructs
and selected under antibiotic pressure for two weeks. After serial dilu-
tions, single colonies originating from unique cell clones were allowed
to grow for 2–4 weeks. 5-HT3 receptor expression was then induced in
48 different clones, and quantiﬁed using speciﬁc labelingwith ﬂuorescent
ligands and quantitative radioligand-binding assays. Clonal selection was
performed on 104 cells of each clone.We obtained stable cell lines for the
construct comprising four consecutive Strep tags (Strep4) in HEK293 and
CHO cells, and for the construct comprising one Strep tag and one
deca-histidine tag (Strep1–His10) inHEK293 cells. All these cells displayed
comparable high levels of surface labeling (Fig. 2a and b). The receptor ex-
pression was further boosted by sodium butyrate (Fig. SI 3) or valproic
acid supplements reaching typically 10 × 106 receptors per cell.
Once the expression system was set up, we optimized the technical
aspects of the cell culture. Indeed routine and efﬁcient mass production
cannot be achieved using normal culture ﬂasks that would quickly re-
sult in overcrowded incubators. Also multi-layer ﬂasks did not provide
a sufﬁcient expansion of the possible surface of culture and are rather
expensive. Revolving roller bottles offered an economical alternative
that permitted to reach a surface of 25,000 cm2 of culture, allowing
mass production of the receptor. Bottles could be reused. However
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Fig. 2. Surface expression, ligand-binding and channel activity of the 5-HT3 receptor. The surface expression and functional assembly of the receptor were demonstrated by labeling
living cells using (a) Chromeo-546 directed toward the Strep tag and (b) 100 nM of the ﬂuorescent antagonist GR-ﬂu. Confocal images were obtained from the stable HEK293 cell
line expressing the Strep4 construct, after induction. c. A typical example of a dose–response curve of currents elicited by serotonin (Strep1–His10 construct expressed in HEK293
cells). Data shown are mean ± sd (n = 3) d. A typical example of radioactive antagonist [3H]-GR65630 binding performed on membrane preparation (stable HEK293 cell line ex-
pressing the Strep4 construct). Data shown are mean ± sd (n = 3). Both curves are ﬁtted with a Hill equation, yielding an EC50 of 7.4 μM and a Hill coefﬁcient of 1.0 in panel c; a Kd
of 0.23 nM and a Hill coefﬁcient of 1.13 in panel d.
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to increase the surface for cell attachment using micro-carriers, which
turned out to be unsuitable for our cell lines that were either sticking
to the carriers or breaking up during harvesting.
We eventually used suspension cell cultures, beneﬁting from the re-
cent development of orbital shaking of cell cultures in common glass-
ware [20]. After adaptation to suspension culture in small volumes, the
HEK293 cell line expressing the receptor displayed high growth rate
and attained 3 × 106 cells/mL with virtually no cell death. Liter scale
cultures for mass production were induced at 2–4 × 106 cells/mL and
harvested one day later. The CHO cells were difﬁcult to adapt and there-
fore all subsequent results described were obtained on HEK293-derived
receptors, unless stated otherwise.
The levels of receptor expression measured on membranes were:
~160 and ~190 pmol/mg (active receptor/total membrane proteins)
for the Strep4 construct in HEK293 (suspension) and CHO (adherent)
cells, respectively, and 100~ pmol/mg for the Strep1–His10 construct in
HEK293 (suspension). Fig. 2d depicts an example of a [3H]-GR65630
binding curve that was used to obtain these numbers. Fig. SI 4 gathers
expression levels for these three cell lines.
Generally, we cultivated 4 L of cells in suspension per week (or
sometimes 30 roller bottles), yielding typically 25 g of biomass, 10 g
of isolated membranes containing 30 mg of 5-HT3 receptor, which ﬁ-
nally generated 1–2 mg of pure pentameric protein after puriﬁcation.
The polyoxyethylene detergent C12E9 was shown to be well suited
for extracting large amounts of the 5-HT3 receptor from the membrane
while retaining its ligand-bindingactivity [14] andwasusedhereat a concen-
tration of 1% (w/v) during solubilization and 0.01% during subsequent steps.
2.3. Afﬁnity puriﬁcation
Puriﬁcation trials of the supernatant of the membrane extract using
the C-terminal His10 tag gave neither satisfactory yields nor sufﬁcientpurity of the recovered protein (data not shown). On the contrary, afﬁn-
ity puriﬁcation on Streptactin superﬂow resin allowed the isolation in a
single step of the receptor with an acceptable degree of purity (Fig. 3c
lanes 1 and 5) and binding activity. The Streptactin resin could be
regenerated and re-used up to 10 times. Only half of the amount of the
receptor present in the solubilized membrane fraction was recovered
after elution. The Strep4 construct was actually generated to try to in-
crease the yield of this step. Finally it turned out that it expressed better
(see above) but behaved similarly during afﬁnity puriﬁcation as the
Strep1–His10 construct bearing a single Strep tag. In SDS-PAGE, the
main band ran above the 50 kDa marker. Tandem mass spectrometry
analysis conﬁrmed that this band corresponded to the mouse serotonin
5-HT3A subunit (27% of sequence coverage), and MALDI-TOF analysis
of the receptor solution gave a peak with m/z = 66 × 103 (Fig. SI 5),
that is a reasonable candidate for the mature glycosylated protein (The
non-glycosylated proteinmass is 60 kDa). Other sharp peaks are present
on SDS gels, which could be attributed to non-disrupted oligomers (also
observed for other CLRs) and to the 75 kDa chaperone BIP (Binding Im-
munoglobulin Protein, also called GRP-78 or HSAPA5, [21]) (identiﬁed
by mass spectrometry; indicated by an asterisk in Fig. 3c lane 1), which
contaminated our preparations. The puriﬁed protein presented a channel
activity, as illustrated by small serotonin-elicited currents in Xenopus
oocytes which were injected with proteoliposomes made up of puriﬁed
receptor reconstituted in asolectin (Fig. 4d).
2.4. The mature receptor is glycosylated but sugars can be removed
The obtained pure receptor is heavily glycosylated with an estimated
mass ratio of 0.1 g of sugar per gram of protein as indicated from both a
colorimetric assay on SDS-PAGE and frommass spectrometry. Heteroge-
neity of the glycosylation pattern in the HEK293-derived protein may
compromise crystallization andwe therefore sought amethod to remove
or homogenize the carbohydrates. First we mutated the N-glycosylation
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been reported to be essential for the correct expression [22], and
indeed single mutants N109S, N174S and N190S displayed dramatically
reduced expression and poor surface labeling by GR-ﬂu (data not
shown). Next we tried to reduce glycosylation during biogenesis. N-
acetylglucosaminyltransferase I (GnTI)-deﬁcient HEK cells are unable
to synthesize complex glycans [23]. We generated stable inducible cell
lines using these cells but they exhibitedweak surface expression and in-
creased the amount of BIP contaminating the preparations (data not
shown).
Finally we used a biochemical approach: PNGase-F is a commer-
cially available N-glycanase that cleaves between the innermost
N-acetylglycosamine of oligosaccharides and asparagine residues. En-
zymatic deglycosylation by PNGase-F removed the majority of sugars
(Fig. 2c lane 2 and Fig. SI 6). The use of cocktails of PNGase F with
other glycanase enzymes did not further reduce the amount of carbo-
hydrates. Because of the high cost of PNGase-F, we optimized the
amount of required enzyme to efﬁciently remove sugars from the
5-HT3 receptor and determined that 5 units of PNGase-F per micro-
gram of receptor was sufﬁcient, with an incubation of 2 h at 37 °C. Be-
cause the 5-HT3 receptor is very thermo-stable, this incubation was
apparently not detrimental [24]. [3H]-GR65630 binding was only
marginally affected by deglycosylation.
2.5. Size-exclusion chromatography and Strep tag removal
In order to isolate the pentameric receptor–detergent complex from
non-native oligomeric species that could be present, we submitted the
5-HT3 receptor to size-exclusion chromatography at different stages of
its puriﬁcation. On a Superose-6 10/300 column able to separate proteins
up to one million Daltons, a pentameric CLR solubilized in detergent
should not be eluted in the void volume. For example, the smaller bacte-
rial receptor GLIC solubilized in DDM runs at ~13.7 mL. We observed no
clear peak that could correspond to the pentameric 5-HT3 receptor in
the elution fraction of the Streptactin afﬁnity puriﬁcation, nor after
deglycosylation (Fig. 4a dotted and red lines). TEV Cleavage of the tag
drastically changed the elution proﬁle and a peak appeared at ~13 mL.
This peak corresponds to an apparent molecular mass of ~500–550 kDa
based on a calibration of the column, an expected value for a pentameric
protein-detergent complex composed of ~5 × 53 = 265 kDa of protein
and an equivalent mass of detergent (for comparison, pure GLIC for in-
stance has a ~1:1 protein:detergentmass ratio). Electronmicroscopy im-
ages of the pooled pentameric peak fractions present rosettes that clearlySize-exclusion
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Fig. 3. Puriﬁcation of the 5-HT3 receptor. a. The sequential steps of the puriﬁcation and b.
SDS-PAGE of elution fractions from the Streptactin column (lane 1), following treatment wi
inating protein BIP and the sharp sign (#) indicates TEV. d. Efﬁcient removal of BIP concom
Streptactin column (lane 4) is re-puriﬁed on the same column following PNGase-F treatmeevoke pentamers (Fig. 4c). This material was concentrated to 10 mg/mL
and used for crystallization trials.
2.6. Preliminary crystallization data
2D crystallization trials of the 5-HT3 receptor were performed using
the cyclodextrin approach [25]. Cyclodextrin has the property to complex
detergentmoleculeswith high selectivity froma protein–lipid–detergent
ternary mixture and thus promotes the formation of 2D crystals. The
crystallization conditions of the 5-HT3 receptor solubilized in C12E9
were screened using a robot, which allowed the removal of detergent
in a controlled and automated manner [26]. Preliminary results of the
2D crystallization trials are presented in Fig. 5a. 5-HT3 receptors are
densely and regularly packed into liposomes but they are not crystalline.
During 3D crystallization trials using vapor diffusion in the hang-
ing drop set-up, we identiﬁed and then optimized a condition that
yielded small crystals within a week (Fig. 5b). The mother liquor
contained 20% PEG 3350, 0.1 M sodium ﬂuoride and 0.1 M Tris buffer
at pH 8.0. We veriﬁed that the crystals were composed of the 5-HT3
receptor by mass spectrometry performed on isolated and carefully
washed crystals. No crystals were obtained under similar conditions
when the receptor from other steps of the puriﬁcation protocol was
used. After cryo-protection the crystals were tested for diffraction at
the Swiss Light Source synchrotron. We could conﬁrm the protein na-
ture of the crystals, but the diffraction was limited to 25 Å. Efforts to
improve the crystals are underway.
3. Discussion
In this report we demonstrated the possibility to obtain milli-
grams of pure and active mouse serotonin 5-HT3 receptor suitable
for structural studies. Generation of stable inducible cell lines for het-
erologous expression and growth in suspension cultures under orbital
shaking proved a cost-effective system to produce, on a routine basis,
membranes containing high levels of receptors. A three-step puriﬁca-
tion protocol (afﬁnity chromatography, enzymatic treatment and
size-exclusion chromatography) yielded protein that satisﬁes the
criteria of quality for crystallography. The receptors showed sufﬁcient
purity, were monodisperse with the correct pentameric stoichiome-
try, and displayed ligand binding and channel gating activities. Pre-
liminary 2D and 3D crystallization trials underlined the potential of
this puriﬁed material for structural studies.dc
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chloride channel from C. elegans, was expressed in baculovirus-infected
Sf9 insect cells [6], which remains the most widely used system for100 nm
ba
Fig. 5. Preliminary 2D and 3D crystallization data. a. Electron micrograph of negatively st
receptor yielding limited diffraction.structural biology of eukaryotic membrane proteins in general. Puriﬁca-
tion of the 5-HT3 receptor derived from insect cells was reported in a
1995 pioneering work, producing a sharp unique protein band on a100 m
ained samples of 5-HT3 receptor 2D crystallization trials. b. 3D crystals of the 5-HT3
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miscroscopy (EM) micrographs, in the submilligram range [13].
The bacterial Escherichia coli has been used for the expression
(fused with a maltose binding protein) of two bacterial homologues
of known structures in [5,8]. Very recently the heterologous expres-
sion of the human 5-HT3A receptor in E. coli has also been reported
[27]. The receptor fused with the P9 bacteriophage envelope protein
was expressed in the membrane fraction, solubilized and puriﬁed in
the negatively charged detergent sarkosyl. This work underlines the
potential of fusion partners to aid in the expression of problematic
proteins, and somehow contradicts the common belief that bacterial
hosts are inadequate for mammalian CLRs.
However, mammalian systems might be more adapted to produce
active and properly assembled mammalian proteins due to their
post-translational modiﬁcation, targeting and membrane insertion ma-
chineries that differ from other cell types. Structures derived from pro-
tein expressed in mammalian cells have recently emerged, for instance
the structure of the rhodopsin in an active state [28] and the structure
the structure of human Rhesus C glycoprotein [29]. In the CLR family,
the use of stable cell lines expressing a chimeric α7/5-HT3 receptor
[30] as well as tetracycline-inducible cell lines expressing the GABA(A)
and the 5-HT3 receptors [31] was reported, yielding expression levels
around 50 pmol/mg. In our laboratory, the 5-HT3 receptorwas previous-
ly expressed inmammalian cells infectedwith Semliki Forest virus (SFV)
[14]. Compared to other systems investigated over the years, our current
expression offers several advantages: it provides high amounts of protein
at a reasonable cost (e.g. compared to the expensive material used to
produce in vitro RNA in the SFV system), and both the quality and the
quantity of receptors are highly reproducible from one batch to another.
The reproducibility of expression in stable cell lines, however, is
hampered by the time required. Development of a new cell line
takes approximately three months, so engineering several cell lines
in parallel requires plenty of time and man-power. In case of failure
to crystallize well-expressed puriﬁed proteins and when screening
for optimal biochemical conditions (detergents, lipids, ligands) is
not successful to reach atomic resolution, one option is to explore
mutants for crystallization attempts. Indeed many recent membrane
protein structures have been obtained from heavily engineered mu-
tant proteins, for example the structure of the thermostabilized
β1-adrenergic receptor [32,33] and the AMPA-subtype glutamate re-
ceptor [34]. The latter bears six deletions at the N-terminus, 36 dele-
tions at the C-terminus and nine point mutations disseminated in the
sequence. The ability to screen many constructs thus appears as an at-
tractive approach for success, which is hard to implement with the
stable inducible cell line expression system used here.
More speciﬁcally, in the case of the CLR family, it is tempting to re-
move the intracellular loop, that is predicted to be partly unstructured
[35,36] and therefore might hinder crystallization. In the mouse
5-HT3A receptor, this loop is 120 residues long and only its C-terminal
part seems to form secondary structures (the MA helix). Receptors of
known structures bear minimal loops (three residues in the engineered
GluCl [6], seven residues in GLIC [5]). We generated constructs with
short loops inspired by the existing structures, but the corresponding
proteins were either not expressed or were completely aggregated.
Maintenance of the correct oligomeric state is a crucial parameter
and has been identiﬁed as a good selection criterion to screen for con-
structs and biochemical conditions susceptible to produce diffracting
crystals [37,38]. Size-exclusion chromatography proﬁles with a
pentameric peak were rarely shown for over-expressed CLRs, except
in the case of CLRs of known structure. Here the afﬁnity-puriﬁed re-
ceptor derived from HEK293 cells, while yielding satisfactory quanti-
ties (Fig. 2c) was eluted in the void volume of a Superose-6 column.
Only after removal of the puriﬁcation Strep tag and of carbohydrates,
the 5-HT3 receptor was eluted as a peak that corresponded to a
pentameric structure, though its shape is not perfect. Visual inspec-
tion of EM micrographs revealed an increased homogeneity afterTEV treatment. Accordingly, the pentameric protein from the pooled
fractions after size-exclusion chromatography yielded crystallization
hits that could not be reproduced with the afﬁnity-puriﬁed or the
deglycosylated receptor.
The reasons for this switch from apparently aggregated to appar-
ently homogeneous pentameric material remain obscure. The sole re-
moval of the 5 × 75 residues of the tag, adding up to approximately
40 kDa in weight for a pentameric receptor, does not explain this;
the tag is hydrophilic, no secondary structure is predicted and there-
fore it should not favor aggregation or cross-linking.
Due to glycosylation of the murine 5-HT3 receptor like most mam-
malian CLRs, oligosaccharides are mandatory for the correct assembly
and plasma membrane targeting; mutagenesis studies have shown
that each of the three N-glycosylation sites is instrumental [22].
N109Q abolishes ligand bindingwhile N174Q andN190Qdrastically de-
crease or abolish surface expression, respectively. Equivalent glycosyla-
tion positions are found in the human 5-HT3 receptor (N81, N147, and
N163) and all of them are mandatory for binding activity and surface
expression [39]. Glycosylation sites are to some extent conserved across
the superfamily. We conﬁrmed that single point mutants present no or
poor binding activity; in our hands, cell lines deﬁcient in the glycosyla-
tion pathways expressed very little receptor at the plasma membrane.
The question remained how to deal with the carbohydrates. Large and
complex sugars can hinder crystallization, and their removal might de-
crease the sample heterogeneity and favor protein–protein packing
contacts. On the contrary, it might be difﬁcult to remove all carbohy-
drates enzymatically. Here, the PNGase-F treatment generated recep-
tors with improved properties in crystallization screens and did not
affect stability or homogeneity.
Accordingly, the enzymatic removal of carbohydrates before crystal-
lization has improved the diffraction quality of crystals for an acetylcho-
line binding protein [40] homologous to the extracellular domain of the
5-HT3 receptor, and removal of the majority of the carbohydrates on
the nACh receptor puriﬁed from Torpedo ﬁsh had essentially no effect
on its structure or on its function [41]. In the latter case, only Endo F1
leads to profound changes in the carbohydrate content but not
PNGase-F, putatively because of its inability to access the cleavage site
close to the surface of the receptor. On the contrary, the mouse 5-HT3
receptor is more sensitive to PNGase-F than to other deglycosidases,
but out of its three N-glycosylation sites, only N174 located in the
cys-loop is conserved between the Torpedo nAChR and the 5-HT3
receptor.
Removal of the contaminant BIP was another reason for PNGase
treatment. BIP was not detectable on SDS gels of the pentameric
peak fractions (after size-exclusion chromatography) after PNGase-F
treatment, whereas traces could be found in the untreated samples.
Moreover, a second round of afﬁnity puriﬁcation after the PNGase-F
treatment showed that BIP was removed (Fig. 2d). BIP is involved in
the folding of nascent proteins and found for the main part in the en-
doplasmic reticulum. It is over-expressed under stress conditions
where up to 5% of BIP can be located at the plasma membrane. Inter-
actions of BIP with nAChR subunits during biogenesis in the ER have
been reported [42], but these interactions were short-lived and at
lower levels compared with interactions with other chaperones. In a
study of yeast-based GPCR expression, upregulation and co-immuno-
precipitation of BIP with the protein of interest was observed [43].
During membrane preparation, we collected not only the plasma
membrane but also most intracellular membranes, which contained a
signiﬁcant amount of over-expressed 5-HT3 receptors [44]. Intracellular
receptors were not stained during in vivo labeling experiments (Fig. 2a
and b), because the cellmembrane is impermeable to the two dyes used
(GR-Flu and Strep-directed-Chromeo-546). Intracellular receptors can
be in any state of assembly or trafﬁcking and contribute to the sample
heterogeneity. It is hard to conclude whether the presence of BIP is
due to the presence of non-mature intracellular receptors or just a con-
sequence of the stress induced by the over-expression. We just note
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the carbohydrates.
4 . Conclusion
Structural biology of cys-loop receptors has progressed during the
last years, with high-resolution structures for GLIC, ELIC and GluCl.
However, no revolution has occurred yet as has been the case for
GPCRs with structures obtained for sixteen distinct receptors, nine
of them in 2012. On the bumpy road towards structure determina-
tion, to our knowledge, we have managed to take the mouse seroto-
nin 5-HT3 receptor a step further than any other mammalian
cys-loop receptor. The cost-effective expression system can be readily
applied to other homomeric members of the superfamily. The effect
of enzymatic treatments on the oligomeric state can be tested and
assessed on a case-by-case basis. In the future, a combination of the
methods presented here with (i) construct screening and (ii) selec-
tion of a stable conformation will hopefully lead to well-diffracting
crystals, X-ray structures, and in turn to a better understanding of
gating and modulation of this important family of receptors.
5 . Material and methods
5.1 . Materials
Restriction and deglycosylation enzymes were purchased from New
England Biolabs. Materials for cell medium like DMEM:F12 medium
with GlutaMAX, fetal bovine serum (FBS), trypsin-EDTA, Dulbecco's
PBS, and blasticidin were from Invitrogen. Hygromycin, G418 and Com-
plete protease inhibitors were from Roche. Tetracycline, sodium buty-
rate, D-desthiobiotin, and asolectin were from Sigma Aldrich. Other
lipids were from Avanti. Nonaoxyethylene n-dodecyl ether (C12E9) was
from Affymetrix. Quipazine was from Tocris Bioscience. [3H]-GR65630
had a speciﬁc activity 79 Ci/mmol and was from Perkin Elmer. GR-ﬂu
was obtained from Ruud Hovius, its synthesis has been described else-
where [18]. Molecular weight markers for SDS-PAGE are Precision Plus
polypeptides from Bio-Rad. Crystallization solutions were from Hamp-
ton research.
5.2 . Molecular cloning
Mouse 5-HT3AR cDNA (NCBI Reference Sequence: NM_001099644.
1 with minor modiﬁcations) was cloned into a pcDNA5-TO or pACMV/
TetO vector. The Strep4 construct has four Strep tags (WSHPQFEK)
separated by a linker sequence (GGGSGGGSGGGS), and it was inserted
together with a single TEV-cleavage sequence (ENLYFQG) at the
N-terminus, between residues SRRR and ATQE. The Strep1–His10 con-
struct is similar except that it has only one N-terminal Strep tag, and a
hexahistidine tag directly following the C-terminus.
5.3 . Cell culture maintenance
T-REx-CHO and T-REx-293 stable cell lines (Invitrogen) were
maintained at 37 °C under a humidiﬁed 5% CO2 atmosphere in tissue
culture-treated ﬂasks (TPP, Switzerland) containing DMEM:F12 me-
dium with GlutaMAX and 10% FBS. To keep the selection pressure
on the stable cell lines, T-REx stable cells were grown in the presence
of appropriate amounts of antibiotics (zeocin, blasticidin, and
hygromycin, for concentrations see above and/or the manufacturers'
manual). When cells reached 80–100% conﬂuence they were de-
tached from the surface by trypsinization or DPBS-EDTA (ﬁnal EDTA
concentration 1 mM), and re-seeded by a 20–50 fold dilution into
fresh medium. When needed the expression of particular proteins
was induced by adding tetracycline and sodium butyrate (2 μg/mL
and 4 mM, respectively). After induction of protein expression, cells
were incubated for 36–48 h until further use.5.4 . Construction of tetracycline-inducible cell lines
T-REx cells were transfected with 1 μg plasmid using Effectene
(Qiagen) in 3.5 cmdiameterwells. After 1–2 days cellswere trypsinized
and diluted 1:20 to 1:100 in 10 cm diameter petri-dishes containing
15 mL of DMEM:F12, 10% FBS, 200 μg/mL hygromycin and 10 μg/mL
blasticidin. After 10–14 days colonies containing around 100 cells start
to appear, which were detached from the surface with trypsin-EDTA
and glass cloning cylinders, and expanded by serial dilution (1:2) in
the rows of 96-well plates. After two weeks single colonies were
harvested and divided over two 12 or 24-well plates. One plate was in-
duced by adding tetracycline and sodium butyrate (2 μg/mL and 4 mM,
respectively) to test the expression of 5-HT3R by radioligand binding on
whole cells (see Section 2.2); the other plate was used for making a fro-
zen stock of clones that displayed good expression.
5.5 . Scale-up and harvesting of CHO roller bottle cultures
Cells were grown in 150 cm2 culture ﬂasks until conﬂuence (one
culture ﬂask per roller bottle) in DMEM:F12 with 10% FCS. Cells
were then trypsinized and transferred to 850 cm2 roller bottles
(Greiner Bio-One) containing 300–350 mL DMEM:F12 supplemented
with 10% FCS and 20 mMHEPES pH 7.4 (to compensate for the loss of
buffer capacity under constrained CO2 availability). Cells were grown
for 8–10 days in the dark at 37 °C, roller bottles rotated at 1 rpm.
5-HT3 receptor expression was induced by the addition of tetracy-
cline (2 μg/mL) and sodium butyrate (4 mM).
Cells were harvested 40–48 h after induction by replacing growth
medium with 50–75 mL DPBS-EDTA. After incubating the cells for
5–10 min while rolling, they started to detach from the surface and
were cleared by decanting into a centrifuge tube. Roller bottles
were washed with DPBS+ and could be reused. Cells from all solu-
tions (growth medium, DPBS-EDTA, and wash buffer) were pelleted
directly after collection. All pellets were combined and washed with
DPBS+, re-pelleted and stored at −80 °C.
5.6 . Scale-up and harvesting of orbitally-shaken suspension cultures
Suspension cell cultures were grown at the EPFL cell culture facil-
ity. The TREx 293 cell line stably expressing the 5-HT3 receptor was
subcultivated two or three times before starting adaptation to
serum-free suspension culture. Trypsinized cells were resuspended at
0.2–0.5 × 106 cells/mL in Ex-cell 293 serum-free medium (Sigma)
supplemented with 4 mM L-glutamine and 5 mg/L phenol red in
TubeSpin bioreactor 50 tubes (TPP, Switzerland). The cells were incubat-
ed under agitation of 180 rpm at 37 °C with 5% CO2 and 80% humidity in
an ISF4-X incubator shaker (KühnerAG, Switzerland). Cellswere regular-
ly subcultivated by dilution until a robust growthwas achieved (typically
going from 0.2 × 106 cells/mL to 2 × 106 cells/mL in 4–5 days). For vol-
umetric scale-up, 50 mL of culture at a density of 0.2 × 106 cells/mL
were transferred into a 250-mL glass bottle. Eventually, the culture was
diluted to 500 mL and then to 2 L in a 5-L glass bottle [20]. The cultures
in the bottles were incubated under agitation at 110–120 rpm in the
presence of 5% CO2 in an ISF4-X incubator shaker. The over-production
of the 5-HT3 receptor was induced by adding 4 μg/mL of tetracycline
and 4 mM of sodium butyrate to the cells at a density of 2–4 × 106/mL.
Cells were collected two days later by centrifugation, washed with
DPBS+, pelleted and stored at−80 °C.
5.7 . Membrane preparation and solubilization
All steps were performed at 4 °C, unless indicated otherwise. Frozen
cell pellets were resuspended in 10 mM HEPES pH 7.4 containing
1 mM EDTA and Complete protease inhibitor cocktail (Roche) and the
cell suspension was homogenized for 2 min using an Ultra-Turrax T25
(IKA). The homogenate was centrifuged at 110,000 g for 1 h and the
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pH 7.4 (buffer A). Membranes were used directly or frozen in liquid ni-
trogen and stored at−80 °C. For solubilization of the 5-HT3 receptor,
C12E9 was added to a ﬁnal concentration of 1% (w/v) and the mem-
branes were solubilized by gentle agitation for 3 h in the presence of
protease inhibitors. This solution was centrifuged for 10 min at
3200 g and subsequently for 1 h at 110,000 g to remove insoluble ma-
terial. The supernatant was ﬁltered on 0.4 μm pore ﬁlters.
5.8 . Afﬁnity puriﬁcation
Ten Streptactin Superﬂow high capacity columns of 5 mL bed vol-
ume each (IBA) were equilibrated with buffer A supplemented with
0.01% C12E9. Solubilized 5-HT3 receptor was bound overnight to the
afﬁnity column using a continuous ﬂow of 1 mL/min. The column
was washed with 2–5 column volumes of 50 mM Tris/HCl, 125 mM
NaCl, 0.01% C12E9, pH 7.4 (buffer B) and eluted with 3 column vol-
umes of the same buffer supplemented with 5 mM D-desthiobiotin.
The elution fractions containing the puriﬁed 5-HT3 receptor were
concentrated to 1 mg/mL.
5.9 . Enzymatic treatments
The receptor solution was incubated for 2 h at 37 °C with PNGase-F
(NEB) under gentle agitation. 5 units of enzyme per μg of receptor was
used. Subsequently the receptorwas incubated overnight in the presence
of TEV protease at 4 °C. 1 μg of TEV per 4 μg of receptor was used.
GLYCOPRO kit (Sigma) was used for selective staining of glycopro-
teins on SDS-PAGE.
5.10 . Size-exclusion chromatography
The receptor was concentrated to ~5 mg/mL and loaded onto a
Superdex 200 10/300 GL or a Superose 6 10/300 GL gelﬁltration col-
umn (GE Healthcare) equilibrated in buffer B.
5.11 . Quantitation of protein
The concentration of 5-HT3 receptor during puriﬁcation was deter-
mined by a one or several of the following methods: radioligand bind-
ing (see below), BCA assay (in the presence of 0.1% Triton X-100) or
measuring A280 absorbance with a Nanodrop 2000 (Thermo Scientiﬁc)
spectrophotometer assuming 1 Abs = 0.5 mg/mL.
5.12 . Radioligand binding assays
Radioligand binding assays were done as described before [14],
with minor modiﬁcations. Cell samples from 12-wells were washed
with DPBS+, detached with DPBS-EDTA, collected by centrifugation
(4 min at 1000 g), and resuspended in 150 μL DPBS+. All other sam-
ples were used without pre-treatment. Samples were diluted in 1 mL
10 mM HEPES pH 7.4 with 0.4 nM [3H]-GR65630 (for solubilized
samples 0.02% C12E9 was included) and equilibrated for 1 h at 4 °C.
Bound and free radioligand were separated by rapid ﬁltration under
vacuum through GF/B glass ﬁber ﬁlters (Whatman) that were
pre-treated for 15 min in 0.5% (w/v) polyethyleneimine, followed
by threefold washing with 3 mL ice-cold 10 mM HEPES pH 7.4.
Then, ﬁlters were transferred to scintillation vials, ﬁlled with 4 mL
of Ultima Gold (PerkinElmer), and radioactivity was counted in a
Tri-Carb 3100 TR liquid scintillation analyzer (Packard). Nonspeciﬁc
binding was determined in the presence of 1 μM quipazine. Experi-
ments were performed in triplicate. The samples were incubated
with six different concentrations of radioligand. The values for the
dissociation constant (Kd) and the total number of binding sites
(Bmax) were determined by plotting speciﬁc binding versus theconcentration of radioligand, followed by least-squares curve ﬁtting
with a Hill equation.
5.13 . Laser-scanning ﬂuorescence microscopy
Cells were grown in DMEM:F12 medium with 10% FCS on glass
cover slides or on 8-well chambered glass slides (Nunc) and 5-HT3
receptor was expressed by adding 2 μg/mL tetracycline 24–48 h be-
fore measuring. Several minutes before measuring the medium was
replaced with DPBS+ to which ﬂuorophores were added if needed.
Gr-ﬂu was used at 50–100 nM and Strep-directed-Chromeo-546
(IBA) at a 1/300 dilution. Binding speciﬁcity was veriﬁed with nega-
tive controls in the presence of a large excess of non-ﬂuorescent li-
gand and with non transfected cells. Fluorescence images were
recorded on a LSM 510 confocal microscope (Zeiss), using appropri-
ate excitation and emission ﬁlters.
5.14 . Reconstitution into proteoliposomes
Lipids were mixed in chloroform and dried at a rotary evaporator.
Dried lipids were resuspended in a buffer of choice at a concentration
of 4 mg/mL using a 21 Gauge needle. Small unilamellar vesicles (SUV)
were prepared by sonication. Liposomes were partly solubilized by
adding C12E9 at a detergent-to-lipid ratio of 0.75 (w/w). After a
10-minute incubation, puriﬁed 5-HT3 receptor was added and incubat-
ed for 30 min at room temperature with gentle agitation (650 rpm).
The detergent was removed by adding wet Bio-Beads SM-2. The
Bio-Beadswere removed and proteoliposomeswere collected by centri-
fugation (110,000 g for 30 min).
5.15 . Electron microscopy
5.15.1. Sample preparation 2D crystallization screening
The concentration of 5-HT3 receptor was adjusted to 1 mg/mL
with dialysis buffer (50 mM Tris, pH7.5, 120 mM NaCl) containing
0.01% of C12E9. Aliquots of the protein solution were mixed with an
equal volume of 1:1 Brain/DOPC lipid mixture (dissolved at
0.1–0.8 mg/mL in 0.5% C12E9) to get a ﬁnal lipid-to-protein ratio of
0.1–0.8. The ternary mixtures (total volume: 40 μL) were transferred
into an Elisa screening plate for automated 2D crystallization trials.
20 μL of a 5% Methyl-β-cyclodextrin solution was required to totally
complex the detergent from the ternary mixtures. The detergent was
removed during 48 h at room temperature using a speed of 400 nL of
cyclodextrin/h.
5.15.2. Electron microscopy
5 μL of diluted samples (reconstituted or single particle 5-HT3 recep-
tor) was adsorbed for 60 s to glow-discharged parlodion carbon-coated
copper grids. The grids were then blotted, washed on ﬁve drops of dou-
ble distilled water and negatively stained on two droplets of 2% uranyl
acetate (pH 4.3) solution. The samples were imaged at a nominal mag-
niﬁcation of 46,000×, 64,000× and 92,000× using a Philips CM10 elec-
tron microscope (Philips, Eindhoven, The Netherlands) operating at
80 kV. Electron micrographs were recorded on a 2000 by 2000 pixel
charge-coupled device camera (Veleta, Olympus soft imaging solutions
GmbH, Münster, Germany) mounted in the 35-mm port of the TEM,
yielding a ﬁnal pixel size of 1.03, 0.74 and 0.52 nm on the specimen
level.
5.16 . 3D crystallization
The sampleswere concentrated on 100-kDa cutoff Amicon centrifugal
ﬁlter units (Millipore). Crystals were obtained at a concentration range of
7–24 mg/mL protein. A Mosquito dispensing robot (TPP Labtech) was
used for screening in the sittingdrop setupwith 100–200 nLdrops. Prom-
ising conditions were repeated manually using hanging drops of 1 μL of
2552 G. Hassaine et al. / Biochimica et Biophysica Acta 1828 (2013) 2544–2552protein solution and 1 μL of a reservoir solution containing 20–30% PEG
3350, 0.1–0.2 M sodium ﬂuoride and 0.1 M Tris–HCl pH 8.0. The volume
of the reservoir solution was 1 mL. Crystals appeared within 1–2 weeks.
They were quickly transferred in a mother solution supplemented with
20–25% glycerol and frozen in liquid nitrogen.
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